Dr. Gerard Criner Discusses Findings from MATINEE Clinical Trial with CHEST Physician

Gerard J. Criner, MD, FACP, FACCP, Chair and Professor of Thoracic Medicine and Surgery at the Lewis Katz School of Medicine at Temple University and Director of the Temple Lung Center, spoke with CHEST Physician about data from the MATINEE clinical trial which found use of mepolizumab as an add-on treatment to optimal triple therapy helps prevent severe exacerbations in patients with COPD.